Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study

Eye

Volumn 22, Issue 12, 2008, Pages 1504-1507

  Leitritz, M ^a   Gelisken, F ^a   Inhoffen, W ^a   Voelker, M ^a   Ziemssen, F ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Age related macular degeneration; Anti VEGF; Bevazicumab; Optical coherence tomography; Pigment epithelial tear; Pigment epithelium detachment

Indexed keywords

BEVACIZUMAB;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PREOPERATIVE EVALUATION; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; RISK FACTOR; THICKNESS;

EID: 65349140005     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.145     Document Type: Article

References (10)

1. Nicolo M, Ghiglione D, Calabria G. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 2006; 16: 770-773.
2. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularization secondary to age related macular degeneration. Br J Ophthalmol 2006; 90: 1207-1208.
3. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 2006; 84: 833-834.
4. Mathews JP, Jalil A, Lavin MJ, Stanga PE. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin): optical coherence tomography and fluorescein angiographic findings. Eye 2007; 21: 1004-1005.
5. Pauleikhoff D, Löffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240: 533-538.
6. Lafaut BA, Aisenbrey S, Vanden Broecke C, Krott R, Jonescu-Cuypers CP, Reynders S et al. Clinicopatological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol 2001; 85: 454-460.
7. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related degeneration. Eye 2008; e-pub ahead of print.
8. Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007; 27: 541-551.
9. Kunze C, Elsner AE, Beasencourt E, Moraes L, Hartnett ME, Treme CL. Spatial extent of pigment epithelial detachments in age-related macular degeneration. Ophthalmology 1999; 106: 1830-1840.
10. Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments, a study of 40 eyes. Arch Ophthalmol 1990; 108: 1687-1693.